Prognostic and Predictive Biomarkers in Familial Breast Cancer
- Author(s)
- Deb, S; Chakrabarti, A; Fox, SB;
- Details
- Publication Year 2023,Volume 15,Issue #4,Page 1346
- Journal Title
- Cancers
- Publication Type
- Review
- Abstract
- Large numbers of breast cancers arise within a familial context, either with known inherited germline mutations largely within DNA repair genes, or with a strong family history of breast and/or ovarian cancer, with unknown genetic underlying mechanisms. These cancers appear to be different to sporadic cases, with earlier age of onset, increased multifocality and with association with specific breast cancer histological and phenotypic subtypes. Furthermore, tumours showing homologous recombination deficiency, due to loss of BRCA1, BRCA2, PALB2 and CHEK2 function, have been shown to be especially sensitive to platinum-based chemotherapeutics and PARP inhibition. While there is extensive research and data accrued on risk stratification and genetic predisposition, there are few data pertaining to relevant prognostic and predictive biomarkers within this breast cancer subgroup. The following is a review of such biomarkers in male and female familial breast cancer, although the data for the former are particularly sparse.
- Publisher
- MDPI
- Department(s)
- Pathology; Laboratory Research
- PubMed ID
- 36831687
- Publisher's Version
- https://doi.org/10.3390/cancers15041346
- Open Access at Publisher's Site
https://doi.org/10.3390/cancers15041346- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-04-06 06:53:44
Last Modified: 2023-04-17 11:52:08